Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB)

Historical Holders from Q2 2018 to Q2 2023

Symbol
CLRB on Nasdaq
Type / Class
Equity / Common Stock, $0.00001 par value per share
Shares outstanding
75,482,273
All holders as of 30 Jun 2023
Q2 2023
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Rosalind Advisors, Inc. 9.9% $3,063,825 7,472,745 Rosalind Advisors, Inc. 31 Dec 2024
ADAR1 Capital Management, LLC 0.1% 2,962 ADAR1 Capital Management, LLC 30 Jun 2025

Institutional Holders of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2023 Q2 0 $0 -$4 0
2023 Q1 5 $4 +$4 $0.8 1
2022 Q3 5 $1,000 -$1,914,000 $200 1
2022 Q2 4,743,321 $1,914,000 -$711,862 $0.4034 24
2022 Q1 6,819,353 $4,688,000 +$178,821 $0.6878 27
2021 Q4 6,591,438 $4,376,000 -$753,116 $0.6642 35
2021 Q3 7,320,806 $6,772,000 -$6,047,136 $0.925 36
2021 Q2 12,486,174 $14,874,276 -$4,685,208 $1.19 42
2021 Q1 15,049,405 $24,219,357 -$5,794,482 $1.61 42
2020 Q4 17,679,705 $36,895,000 +$23,156,825 $2.08 38
2020 Q3 3,452,402 $4,282,000 +$542,449 $1.24 19
2020 Q2 3,006,006 $3,849,000 +$1,971,582 $1.28 21
2020 Q1 1,466,241 $1,936,000 +$222,918 $1.31 15
2019 Q4 1,295,959 $2,917,000 -$498,988 $2.25 9
2019 Q3 1,506,159 $3,006,054 -$985,030 $2 12
2019 Q2 1,985,734 $4,329,059 +$3,787,212 $2.18 11
2019 Q1 246,868 $581,063 -$32,864 $2.35 9
2018 Q4 262,671 $407,000 +$89,332 $1.55 9
2018 Q3 203,047 $611,000 +$567,000 $3.01 9
2018 Q2 72,383 $44,000 +$44,000 $0.6079 1